Current Opinion in Cardiology

Papers
(The TQCC of Current Opinion in Cardiology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Racial and ethnic disparities in heart failure: current state and future directions61
Impact of social determinants of health on cardiovascular disease prevention48
Hypertension and race/ethnicity43
Measuring LDL-cholesterol: what is the best way to do it?36
Hypertension and diabetes mellitus: highlights of a complex relationship31
Gut microbiome and cardiovascular disease29
Functional characterization of long noncoding RNAs28
Hypertension in obesity25
Genetics of hypertriglyceridemia and atherosclerosis25
Artificial intelligence and machine learning in aortic disease24
COVID-19 myocarditis and long-term heart failure sequelae23
Recent trends in acute myocardial infarction among the young22
COVID-19 will forever change the landscape of telemedicine21
Genetics of dilated cardiomyopathy21
Nutrition and physical activity recommendations from the United States and European cardiovascular guidelines: a comparative review19
Triglycerides and cardiovascular disease18
Artificial intelligence in pediatric cardiology: taking baby steps in the big world of data17
Health anxiety among adults with congenital heart disease16
Racial disparities in Coronavirus Disease 2019 (COVID-19) outcomes16
Risk factors of sudden cardiac death in hypertrophic cardiomyopathy15
Hypertension in children15
Endocan: a new marker of endothelial function15
Artificial intelligence in cardiovascular medicine15
The aberrant subclavian artery: approach to management14
Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure14
The placenta as the window to congenital heart disease14
Statin intolerance: new data and further options for treatment13
Pulmonary hypertension associated with left-sided heart failure13
Current management of the vascular subtype of Ehlers–Danlos syndrome12
Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology12
Mobile health in preventive cardiology: current status and future perspective12
Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal?12
Racial differences in outcomes after receiving advanced heart failure therapies12
Epidemiology and risk factors for stroke in young individuals: implications for prevention11
RNA therapeutics for cardiovascular disease11
Coronavirus disease 2019: a comprehensive review and meta-analysis on cardiovascular biomarkers10
RNA-based therapeutics in cardiovascular disease10
Cybersecurity threats to cardiac implantable devices: room for improvement10
Generalizability of Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial in patients with a history of coronary artery bypass graft surgery10
Genetics of atrial fibrillation10
Emergent expansion of clinical epigenetics in patients with cardiovascular diseases10
The brave new world of genetic testing in the management of the dyslipidaemias10
Molecular genetics of human hypertension10
Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?9
Mitral valve surgery for rheumatic heart disease: replace, repair, retrain?9
Disparities in acute decompensated heart failure9
Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular disease9
Management of ventricular arrhythmias in patients with LVAD9
Pulsed field ablation: a promise that came true9
Machine learning: at the heart of failure diagnosis9
Two-year outcomes from the PARTNER 3 trial: where do we stand?9
Cardiac rehabilitation for coronary artery disease: latest updates8
Arrhythmogenic right ventricular cardiomyopathy in the pediatric population8
Medical management of resistant hypertension: the role of sodium-glucose cotransporter 2 inhibitors (SGLT2i)8
Clinical trials of acute mechanical circulatory support in cardiogenic shock and high-risk percutaneous coronary intervention8
Atrial arrhythmias in patients with left ventricular assist devices8
Every child with congenital heart disease should be exercising8
The impact of socioeconomic status and race on the outcomes of congenital heart disease8
Transcatheter mitral valve repair and replacement: the next frontier of transcatheter valve intervention8
The evolving role of coronary artery calcium in preventive cardiology 30 years after the Agatston score8
Update on pediatric pulmonary arterial hypertension8
Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events8
Genetics of age-related clonal hematopoiesis and atherosclerotic cardiovascular disease7
Transcatheter mitral valve replacement: an update7
Multimodality cardiac imaging and new display options to broaden our understanding of the tricuspid valve7
A tale of two balloons: technical and procedural difference between cryoballoon systems7
Evaluation of coronary stenosis versus plaque burden for atherosclerotic cardiovascular disease risk assessment and management7
Pulmonary hypertension in heart failure7
Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill?7
Temporary mechanical circulatory support devices: updates from recent studies7
The emerging role of cardiac contractility modulation in heart failure treatment7
Challenges in diagnosis and management of coarctation of the aorta7
Epigenetic remodeling in heart failure with preserved ejection fraction7
Bicuspid aortic valve associated aortopathy: 2022 guideline update6
New findings bearing on the prevention, detection and management of high blood pressure6
Pharmacologic therapy for pulmonary artery hypertension6
Myocardial infarction with nonobstructive coronary artery disease (MINOCA): a review of pathophysiology and management6
N-3 polyunsaturated fatty acids for cardiovascular risk6
Cardiovascular implications and complications of the coronavirus disease-2019 pandemic: a world upside down6
Optimal medical therapy after coronary artery bypass grafting: a primer for surgeons6
Mobile health technologies in the diagnosis and management of atrial fibrillation6
Ischaemia without obstructive coronary artery disease: the pathophysiology of microvascular dysfunction6
Regionalization of congenital cardiac surgical care: what it will take6
Percutaneous left atrial appendage occlusion6
The landscape of cardiogenic shock: epidemiology and current definitions6
Opportunities for improved cardiovascular disease prevention in oncology patients6
Arrhythmias and sudden cardiac death in post-cardiac transplant patients6
Cardiovascular disease prevention in individuals with underlying chronic inflammatory disease6
Global interventions in hypertension: new and emerging concepts6
The cardiac surgeon's guide to artificial intelligence6
The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors6
A comparison of surgical, total percutaneous, and hybrid approaches to treatment of combined coronary artery and valvular heart disease5
Representation of Black patients in heart failure clinical trials5
Supporting the Ross procedure: preserving root physiology while mitigating autograft dilatation5
The genetics of left ventricular noncompaction5
Thin, very thin, or ultrathin-strut biodegradable or durable polymer-coated drug-eluting stents5
Secondary prevention after CABG: do new agents change the paradigm?5
Atypical atrial flutter: review of mechanisms, advances in mapping and ablation outcomes5
The shock team: a multidisciplinary approach to early patient phenotyping and appropriate care escalation in cardiogenic shock5
Stress cardiac MRI in stable coronary artery disease5
Coronary artery disease in patients with cancer: challenges and opportunities for improvement5
The current landscape of lipoprotein(a) in calcific aortic valvular disease5
Update on cardiovascular risk in nonalcoholic fatty liver disease5
Surgical options for aortic root aneurysm disease: which procedure, which patient5
Antiplatelet therapy in percutaneous coronary intervention: latest evidence from randomized controlled trials5
Are the current evaluation tools for advanced therapies biased?5
Cardiovascular effects of preeclampsia5
Long noncoding RNAs in cardiovascular disease5
Percutaneous management of coronary bifurcation lesions: current perspective5
0.040190935134888